Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Molecular imaging in drug development
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Phases and phase transitions of the phosphatidylcholines
1998 Standout
Vulvovaginal candidosis
2007 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Treatment of Candida albicans fungaemia with fluconazole
1993
Systemically Administered Antifungal Agents
1992
Oral Anticoagulant Therapy
2012 Standout
Secondary mycosis in surgery: Treatment with fluconazole
1989
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients
1988
Antifungal Agents. Part II. The Azoles
1999
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: independence from sympathetic nervous and adrenocortical systems
1999
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis
1995
Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis
2001
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
2004 Standout
Anti-CandidaDrugs — The Biochemical Basis for Their Activity
1987
The molecular basis of blood coagulation
1988 Standout
Human Mycoses: Drugs and Targets for Emerging Pathogens
1994 Science
Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats
1998
Recent developments in pradimicin-benanomicin and triazole antibiotics
1997
Fluconazole
1990
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Design and Evaluation of a Systemically Active Agent, Fluconazole
1988
Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis
1995
Pharmacokinetic Imaging
2002
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
1992
Animal Models: Usefulness for Studies of Fungal Pathogenesis and Drug Efficacy in Aspergillosis
1992
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDS
1989
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
2003
A clinical study of fluconazole for the treatment of deep mycoses
1989
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Murine Teratology of Fluconazole: Evaluation of Developmental Phase Specificity and Dose Dependence
2005
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: Successful treatment with fluconazole, a new orally active antifungal agent
1989
Siccanin Rediscovered as a Species-Selective Succinate Dehydrogenase Inhibitor
2009 StandoutNobel
Antifungal triazoles induce malformations in vitro
2001
Antifungal agents: An overview. Part II
1994
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
History of the development of azole derivatives
2004
Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients
1994
Plant cell cultures: Chemical factories of secondary metabolites
2002 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Antifungal agents: An overview. Part I
1994
Fluorine in medicinal chemistry
2007 Standout
The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin
1975
Deficiency of protein C in congenital thrombotic disease.
1981 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Prostacyclin and Blood Coagulation
1981 StandoutNobel
Efficacy of D0870 treatment of experimental Candida vaginitis
1997
Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Antifungal agents: chemotherapeutic targets and immunologic strategies
1996
Zygomycetes in Human Disease
2000 Standout
Platelets, Thrombosis and Drugs
1975
Ocular Pharmacokinetics of Saperconazole in Rabbits
1992
Release of platelet constituents by monosodium urate crystals.
1977
Studies of Glutamate Dehydrogenase
1973
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
1999 Standout
Membrane growth can generate a transmembrane pH gradient in fatty acid vesicles
2004 StandoutNobel
Conazoles
2010
Deviations from michaelis-menten behaviour of plant glutamate dehydrogenase with ammonium as variable substrate
1980 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
Fluconazole therapy for pulmonary mucormycosis complicating.
1989
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis
1988
Cyclodextrin Drug Carrier Systems
1998 Standout
Amino Acid Biosynthesis in the Halophilic Archaeon Haloarcula hispanica
1999 StandoutNobel
Lipid Phase Transitions and Procoagulant Activity
1979
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice
1995
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models
1997
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Vitamin K, Prothrombin, and γ‐Carboxyglutamic Acid
1978
Comparison of Itraconazole and Fluconazole Treatments in a Murine Model of Coccidioidal Meningitis
2006
Changes in membrane phospholipid distribution during platelet activation
1983
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum
1996
Mechanism and Scope of Base‐Controlled Catalyst‐Free N‐Arylation of Amines with Unactivated Fluorobenzenes
2016 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Overview of medically important antifungal azole derivatives
1988
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations
1997
Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid.
1976
Systemic Antifungal Agents
1998
Membrane and lipid involvement in blood coagulation
1978
Calelectrin self-aggregates and promotes membrane aggregation in the presence of calcium.
1982 StandoutNobel
Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
2011
Mesomorphic behaviour of some phospholip1ds with aliphatic alcohols and other non-ionic substances
1973
Permeabilized cells
1982
A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.
1976
Characterization and Quantitation of the Pharmacodynamics of Fluconazole in a Neutropenic Murine Disseminated Candidiasis Infection Model
1999
Modulation of membrane fusion by calcium-binding proteins
1982
Isolation and Properties of a Thrombin-sensitive Protein of Human Platelets
1972
A Cell-based Model of Hemostasis
2001 Standout
Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease
1995
A spectrum of partially carboxylated prothrombins in the plasmas of coumarin-treated patients
1977
Guidelines for Treatment of Candidiasis
2004 Standout
Adsorption of monovalent cations to bilayer membranes containing negative phospholipids
1979
Fluconazole penetration in cerebral parenchyma in humans at steady state
1995
Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis
1990
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei
1989
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Properties of meso-alpha,epsilon-diaminopimelate D-dehydrogenase from Bacillus sphaericus.
1980
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Works of S. Jevons being referenced
Peptidoglycan Transpeptidase Inhibition in Pseudomonas aeruginosa and Escherichia coli by Penicillins and Cephalosporins
1979
Ticonazole, a New Imidazole-Antifungal Agent for the Treatment of Dermatomycoses
1983
Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.
1983
Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative
1979
Interactions of phosphatides with some paraffin-chain salts
1970
Tioconazole in the Treatment of Fungal Infections of the Skin
1983
Fluconazole and testosterone: in vivo and in vitro studies
1988
Tioconazole in the Treatment of Vaginal Candidiasis
1983
Complexes of Prothrombin with Calcium Ions and Phospholipids
1972
Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans
1985
Biochemistry of blood platelets. Interaction of activated factor X with platelets
1971